honeywell and recipharm to speed development of inhalers with a nearzero global warming potential propellant global africa algeria english angola english kenya english morocco french nigeria english south africa english tunisia french asia pacific australia english china chinese india english indonesia indonesian japan japanese malaysia english republic of korea korean philippines english thailand english vietnam vietnamese europe austria german belgium french belgium dutch bulgaria bulgarian czech republic english denmark danish finland finnish france french germany german hungary hungarian italy italian netherlands dutch norway norwegian poland polish romania english slovakia slovak switzerland french switzerland german turkey turkish united kingdom english latin america brazil portuguese mexico spanish middle east egypt english saudi arabia english saudi arabia arabic united arab emirates english united arab emirates arabic north america canada english canada french united states english contact close industries industries what we do our products aerospace commercial buildings energy healthcare ithightech life sciences logistics and warehouses retail utilities company company about us investors ventures quantum history sustainability news careers global africa algeria english angola english kenya english morocco french nigeria english south africa english tunisia french asia pacific australia english china chinese india english indonesia indonesian japan japanese malaysia english republic of korea korean philippines english thailand english vietnam vietnamese europe austria german belgium french belgium dutch bulgaria bulgarian czech republic english denmark danish finland finnish france french germany german hungary hungarian italy italian netherlands dutch norway norwegian poland polish romania english slovakia slovak switzerland french switzerland german turkey turkish united kingdom english latin america brazil portuguese mexico spanish middle east egypt english saudi arabia english saudi arabia arabic united arab emirates english united arab emirates arabic north america canada english canada french united states english contact search you are browsing product catalog for contenthoneywellbtusensearchhtml title subtitle press media honeywell and recipharm to speed development of inhalers with a nearzero global warming potential propellant honeywell and recipharm to speed development of inhalers with a nearzero global warming potential propellant partnership will reduce environmental footprint of pressurized metered dose inhalers and accelerate transition to lower greenhouse gas respiratory care august 17 2023 morris plains nj and stockholm aug 17 2023 prnewswire honeywell nasdaq hon and global contract development and manufacturing organization cdmo recipharm have today announced a commercial partnership that will speed the development of pressurized metered dose inhalers pmdis that use honeywells nearzero global warming potential gwp propellant as many as 384 million people globally suffer from chronic obstructive pulmonary disease copd and about 262 million people suffer from asthma 1 many of these patients are treated using pmdis that have a high global warming potential due to the use of hydrofluoroalkanes hfas as propellants honeywell solstice air hfo1234zee cgmp is a hydrofluoroolefin hfo propellant in clinical development today for pmdis that has 999 less global warming potential than hfas in addition honeywell solstice air is nonflammable nonozonedepleting and volatile organic compound vocexempt under federal and state guidelines honeywell is making great strides to offer patients who rely on pmdis a lower greenhouse gas solution to meet their medical needs said laura reinhard vice president and general manager honeywell foam and industrial products through our collaboration with recipharm the increased use of nearzero gwp propellant used in pmdis will help reduce the environmental impact of the lifesaving medical treatments patients need without sacrificing performance as the first cdmo to partner with honeywell for use of solstice air this collaboration significantly accelerates and simplifies our customers pathway to develop the next generation of low greenhouse gas pmdis said chris hirst president of recipharms advanced delivery systems business unit our collaboration is supported by recipharms investment in manufacturing with hfo1234zee cgmp at our holmes chapel united kingdom site and the further development of the bespak valve range to ensure the required product performance the partnership with honeywell follows recipharms announcement that it is expanding its pmdi product development and manufacturing capabilities to accommodate increased demand from pharmaceutical companies research will be conducted at recipharms dedicated inhalation development facility in research triangle park nc recipharm customers will also benefit from the companys marketleading bespak valves which have been optimized to ensure performance with products containing honeywell solstice air as the propellant honeywell has invested more than 1 billion in research development and new capacity for its solstice technology which has applications in refrigerants blowing agents aerosols and solvents use of honeywell solstice technology has helped avoid the potential release of the equivalent of more than 326 million metric tons of carbon dioxide into the atmosphere equal to the carbon emissions from nearly 70 million gasolinepowered passenger vehicles per year 2 for more information on honeywell solstice air its applications and impact visit httpssustainabilityhoneywellcomusen honeywell is committed to achieving carbon neutrality in its operations and facilities by 2035 about 60 of honeywells 2022 new product introduction research and development investment was directed toward environment social and governance esg oriented outcomes for customers 3 as a cdmo focusing on sustainability recipharm is committed to the science based targets initiative sbti it has set ambitious and transparent targets to reduce its emissions from direct operations by 42 and emissions from the full valuechain by 25 by 2030 it also has b rating for climate from cdp which indicates recipharm is showing clear evidence of managing its climate impact to find out more read recipharms sustainability report here about honeywell honeywell wwwhoneywellcomusen delivers industryspecific solutions that include aerospace products and services control technologies for buildings and industry and performance materials globally our technologies help aircraft buildings manufacturing plants supply chains and workers become more connected to make our world smarter safer and more sustainable for more news and information on honeywell please visit wwwhoneywellcomusennews about recipharm recipharm is a leading contract development and manufacturing organisation cdmo in the pharmaceutical industry employing almost 9000 employees recipharm offers manufacturing services of pharmaceuticals and biologics in various dosage forms production of clinical trial material and apis pharmaceutical product development and development and manufacturing of medical devices recipharm manufactures several hundred different products for customers ranging from big pharma to smaller research and development companies the company operates development and manufacturing facilities in france germany india israel italy portugal spain sweden the uk and the us and is headquartered in stockholm sweden for more information on recipharm and our services please visit wwwrecipharmcom 1 the global asthma network the global asthma report 2022 online available at httpswwwglobalasthmanetworkorg world health organization the top 10 causes of death online available at httpswwwwhointnewsroomfactsheetsdetailthetop10causesofdeath adeloye d et al global health epidemiology reference group gherg global and regional estimates of copd prevalence systematic review and metaanalysis j glob health 2015 5 2 020415 2 calculations are based on actual sales of solstice products in lbs from jan 2010 through dec 2022 and utilize the epa ghg equivalency calculator for conversion 3 methodology for identifying esgoriented solutions is available at investorhoneywellcom see esgesg informationidentification of esgoriented offerings stephanie agresti email sustainability what we do toggle view honeywell forge our industries our products quantum solutions industries toggle view aerospace commercial real estate energy healthcare ithightech life sciences logistics warehouse retail utilities company toggle view about us history investors leadership inclusion diversity news toggle view news press media careers toggle view careers job search contact us toggle view support business inquiries employee access follow us linkedin facebook twitter youtube instagram scroll to top copyright 2023 honeywell international inc terms conditions privacy statement your privacy choices cookie notice global unsubscribe